Post-earnings recap
Reported
Thu, Jan 26, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report shows a positive surprise in EPS, which contributed to a slight increase in the stock price. The lack of revenue data and guidance may leave some investors cautious. Overall, the company appears to be on a solid path, focusing on innovation and customer satisfaction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.66 | N/A | +3.75% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and meeting customer needs.